Vasopressor
11
3
3
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 42/100
9.1%
1 terminated out of 11 trials
75.0%
-11.5% vs benchmark
27%
3 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (11)
Canadian Critical Care Comparative Effectiveness Platform
Caffeine and Prophylactic Noradrenaline Requirement During Cesarean Delivery
Effect of Vasopressin Versus Norepinephrine on Post-operative Mean Pulmonary Arterial Pressure Following Pulmonary Endarterectomy Surgery,
The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery
Management of Postspinal Anesthesia Hypotension During Elective Cesarean Section: Baby Norepinephrine Versus Ephedrine
Comparison of Two Doses of Norepinephrine in Preventing Hypotension After Spinal Anesthesia
ImPortance of Arterial Measurement Sites (IPAMS) on Intraoperative Hemodynamic Management
Observational Study About the Use of Perfusion Index to Use Vasopressor in Sepsis
Postoperative Vasopressor Usage: SQUEEZE
Treatment of Vasopressor-induced Ischemia With Botulinum Toxin A
Effects of Different Kinds, Different Doses of 5-HT3 Receptor Antagonists on Prevention of Hypotension